A detailed history of Parkside Financial Bank & Trust transactions in Novartis Ag stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 3,693 shares of NVS stock, worth $383,370. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,693
Previous 3,986 7.35%
Holding current value
$383,370
Previous $424,000 -0.0%
% of portfolio
0.06%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$106.13 - $120.89 $31,096 - $35,420
-293 Reduced 7.35%
3,693 $424,000
Q2 2024

Aug 05, 2024

SELL
$92.57 - $107.37 $16,755 - $19,433
-181 Reduced 4.34%
3,986 $424,000
Q1 2024

May 01, 2024

SELL
$95.27 - $108.47 $118,706 - $135,153
-1,246 Reduced 23.02%
4,167 $403,000
Q4 2023

Feb 01, 2024

BUY
$92.27 - $101.54 $217,295 - $239,126
2,355 Added 77.01%
5,413 $546,000
Q2 2023

Aug 15, 2023

SELL
$92.52 - $104.91 $8,511 - $9,651
-92 Reduced 2.92%
3,058 $308,000
Q1 2023

May 04, 2023

SELL
$80.03 - $92.81 $3,121 - $3,619
-39 Reduced 1.22%
3,150 $289,000
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $2,946 - $3,608
39 Added 1.24%
3,189 $289,000
Q3 2022

Nov 01, 2022

SELL
$74.61 - $87.26 $2,611 - $3,054
-35 Reduced 1.1%
3,150 $240,000
Q2 2022

Jul 13, 2022

BUY
$80.52 - $93.75 $805 - $937
10 Added 0.31%
3,185 $269,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $7,129 - $8,065
89 Added 2.88%
3,175 $279,000
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $51,565 - $57,020
-647 Reduced 17.33%
3,086 $270,000
Q3 2021

Oct 29, 2021

BUY
$81.78 - $95.14 $1,962 - $2,283
24 Added 0.65%
3,733 $306,000
Q2 2021

Aug 06, 2021

BUY
$85.24 - $94.15 $11,763 - $12,992
138 Added 3.86%
3,709 $339,000
Q1 2021

May 10, 2021

SELL
$83.5 - $98.47 $12,358 - $14,573
-148 Reduced 3.98%
3,571 $305,000
Q4 2020

Feb 09, 2021

BUY
$78.07 - $94.43 $10,149 - $12,275
130 Added 3.62%
3,719 $352,000
Q3 2020

Nov 06, 2020

SELL
$82.14 - $91.0 $118,281 - $131,040
-1,440 Reduced 28.63%
3,589 $312,000
Q2 2020

Aug 10, 2020

SELL
$80.93 - $91.1 $4,532 - $5,101
-56 Reduced 1.1%
5,029 $440,000
Q1 2020

May 05, 2020

SELL
$70.67 - $99.01 $22,119 - $30,990
-313 Reduced 5.8%
5,085 $419,000
Q4 2019

Jan 30, 2020

BUY
$84.35 - $95.37 $4,892 - $5,531
58 Added 1.09%
5,398 $511,000
Q3 2019

Nov 05, 2019

BUY
$85.54 - $94.26 $8,554 - $9,426
100 Added 1.91%
5,340 $464,000
Q2 2019

Aug 06, 2019

SELL
$75.4 - $92.8 $4,448 - $5,475
-59 Reduced 1.11%
5,240 $478,000
Q1 2019

May 01, 2019

BUY
$75.32 - $86.15 $451 - $516
6 Added 0.11%
5,299 $509,000
Q4 2018

Jan 31, 2019

SELL
$73.66 - $82.02 $9,944 - $11,072
-135 Reduced 2.49%
5,293 $454,000
Q3 2018

Oct 12, 2018

BUY
$66.94 - $77.43 $51,075 - $59,079
763 Added 16.36%
5,428 $468,000
Q2 2018

Aug 03, 2018

SELL
$64.91 - $73.36 $2,661 - $3,007
-41 Reduced 0.87%
4,665 $352,000
Q1 2018

May 02, 2018

SELL
$70.39 - $84.15 $9,150 - $10,939
-130 Reduced 2.69%
4,706 $381,000
Q4 2017

Feb 05, 2018

BUY
$72.33 - $77.64 $25,604 - $27,484
354 Added 7.9%
4,836 $406,000
Q3 2017

Oct 27, 2017

BUY
$74.14 - $77.27 $332,295 - $346,324
4,482
4,482 $384,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.